Medtronic has received a CE Mark for its Guardian Connect mobile continuous glucose monitor (CGM) and app. The company will begin selling the system in select countries in Europe, Asia, and Latin America in Q2 2017 and expects to receive FDA clearance to launch the device in the US around that same time.
The Dublin, Ireland-based company already has an FDA and CE cleared connected CGM called...
Medtronic has launched its MiniMed Connect system, which allows people with diabetes who use both a Medtronic continuous glucose monitor (CGM) and a Medtronic insulin pump to see data from both device on their smartphone, and send it to their caregiver.
"It’s part of our plan to become a holistic diabetes management company," Annette Brüls, President of the Diabetes Service and Solutions business...
Germantown, Maryland-based continuous glucose monitor device maker Senseonics raised $10 million, according to an SEC filing.
The company has not yet responded to a request for comment.
Existing investors include Anthem Capital, Delphi Ventures, Greenspring Associates, Healthcare Ventures, and New Enterprise Associates. This brings the company’s total funding to at least $94 million to date....
Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone. At the same time, Medtronic announced a partnership with Samsung to optimize the viewing of this CGM and pump data.
The MiniMed Connect device is a keychain-sized device that users of...
Medtronic has developed a Bluetooth-enabled continuous glucose monitoring system for patients with diabetes, that will connect to an iOS app, Medtronic Global Program Marketing Manager Samantha Katz announced from the stage at Health 2.0 in Santa Clara, California.
MobiHealthNews has learned that though the new system is not yet FDA cleared, it will start a "pivotal clinical trial" later this...
